Jefferies Maintains a 'Buy' on Thermo Fisher Scientific (TMO); Q4 Review

Jefferies maintains a 'Buy' on Thermo Fisher Scientific (NYSE: TMO) price target raised $1 to $59.

Jefferies analyst says, "Post TMO's 4Q11, we are raising 2012 EPS forecast to $4.75 (from $4.70) to account for a lower tax rate (+$0.14), lower share count (+$0.06), and modestly better organic revenue growth outlook (+$0.04), partially offset by adverse FX headwinds (-$0.16) and a slightly weaker core TMO profit margin outlook (- $0.03)."

"The clean 4Q11 organic revenue upside and credible 2012 organic revenue growth outlook satisfy two critical components of rebounding investor sentiment on the shares, in our view."

For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.

Shares of Thermo Fisher Scientific closed at $54.71 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Thermo Fisher Scientific (TMO) PT Raised to $690 at HSBC
• Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
• Science Applications (SAIC) PT Raised to $123 at UBS